Sport Investors League
  • Politics
  • Stocks
  • Investing
  • Business

Sport Investors League

  • Politics
  • Stocks
  • Investing
  • Business
Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

by admin December 20, 2024
December 20, 2024
RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
5 Best-performing Canadian Nickel Stocks of 2024
next post
Forum Comments on Share Price

Related Posts

Top 10 Copper-producing Companies

February 12, 2025

Premier1 Lithium

May 31, 2024

Matt Geiger: Juniors at Inflection Point, Plus “Insane”...

October 31, 2024

Top 10 Tin-producing Countries (Updated 2024)

December 18, 2024

Aether Global Innovations Corp. Announces Resignation of its...

August 10, 2024

Zijin Mining in Talks to Acquire Stake in...

January 11, 2025

Mining Industry’s Exploration Spending Lagging, Will Budgets Grow...

March 19, 2025

Forward Water Technologies Announces Commercial Update

June 1, 2024

Issue of Equity and TVR

December 7, 2024

December 2024 Quarterly Results Presentation

January 29, 2025

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent

    • The Best Five Sectors, #25

      July 1, 2025
    • Pullbacks & Reversals: Stocks Setting Up for Big Moves!

      July 1, 2025
    • Is This Rally Sustainable? You Better Bet Your Bullish Sweet Dollar It Is!

      July 1, 2025
    • Trump to sign order lifting sanctions on Syria

      July 1, 2025
    • House Freedom Caucus targets Trump’s ‘big, beautiful bill’ with concerns about budget deficit

      July 1, 2025

    Categories

    • Business (1,005)
    • Investing (2,505)
    • Politics (3,115)
    • Stocks (1,107)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sportinvestorsleague.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 sportinvestorsleague.com | All Rights Reserved